This study reports the association of ICS use and the risk of type 2 diabetes mellitus (T2DM) in Swedish patients with COPD using data from real-world, primary care settings. A total of 7078 patients with COPD were included in this analysis and the 5-year cumulative incidence rate per 100,000 person years was 1506.9. The yearly incidence rate per 100,000 person years ranged from 850 to 1919. Use of ICS especially at a high dose in patients with COPD was related to an increased risk of T2DM.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576803 | PMC |
| http://dx.doi.org/10.1038/s41533-020-00207-7 | DOI Listing |
Publication Analysis
Top Keywords
patients copd
12
risk type
8
type diabetes
8
incidence rate
8
rate 100000
8
100000 person
8
person years
8
inhaled corticosteroids
4
corticosteroids risk
4
diabetes swedish
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!